Electric shocks plus bleomycin: a new hope for vascular malformations?
NCT ID NCT07579962
First seen May 12, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study tests a new treatment called bleomycin electrosclerotherapy (BEST) for people with low-flow vascular malformations (abnormal blood or lymph vessels). The treatment combines a drug (bleomycin) with short electrical pulses to make the drug work better and shrink the malformation. The study will include 140 adults whose malformations did not improve or came back after previous treatments. The main goal is to see how much the lesion shrinks 3 months after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.